Skip to product information
1 of 2

ACVR2A His Tag Protein, Human

ACVR2A His Tag Protein, Human

Catalog Number: UA085066 Brand: UA BIOSCIENCE
Price:
Regular price $370 USD
Regular price Sale price $370 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms ACVR2, ACTRII, activin A receptor type II
Accession P27037
Amino Acid Sequence

Pro191-Ile488 with His Tag at the N-Terminus

Expression System Baculovirus-InsectCells
Molecular Weight

35-40kDa (Reducing)

Purity >95% by SDS-PAGE
Conjugation Unconjugated
Tag His Tag
Physical Appearance Liquid
Storage Buffer

50mM Tris, 150mM NaCl, pH7.5, 1mM DTT, 10%Glycerol

Stability & Storage

Stable for 12 months upon stored at -80℃ from the date of receipt. And avoid repeated freeze-thaws cycles.

Reference

1. Lee, S.J., et al. (2005). Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proceedings of the National Academy of Sciences, 102(50), 18117-18122.
2. Olaru, A., et al. (2003). Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors. Laboratory Investigation, 83(12), 1867-1871.
3. Rossi, M.R., et al. (2005). Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells. Cancer Genetics and Cytogenetics, 163(2), 123-129.

Background

ACVR2A (Activin A Receptor Type 2A) is a transmembrane serine/threonine kinase receptor that serves as a type II receptor for the TGF-β superfamily. It is encoded by the gene located on chromosome 2q22.3 and is expressed in multiple tissues including brain, testis, intestine, liver, and kidney.

Mechanism of Action: ACVR2A functions as a constitutively active kinase that binds ligands including activin A, activin B, inhibin A, GDF8/myostatin, and GDF11. Upon ligand binding, ACVR2A recruits and phosphorylates type I receptors (ACVR1B/ALK4, ACVR1/ALK2, or ACVR1C/ALK7) within their GS domains. The activated type I receptor then phosphorylates SMAD2 and SMAD3, which complex with SMAD4 and translocate to the nucleus to regulate gene transcription. Inhibitory SMAD7 can block this signaling cascade.

Protocol

Assay protocol

Principle: The ACVR2A assay is performed using the ADP-GloTM Kinase Assay kit which quantifies the amount of ADP produced by the ACVR2A reaction. The ADP-GloTM Reagent is added to terminate the kinase reaction and to deplete the remaining ATP, and then the Kinase Detection Reagent is added to convert ADP to ATP and to measure the newly synthesized ATP using luciferase/luciferin reaction.

Materials

1.Kinase assay buffer(5X): 200 mM Tris-HCl, pH 7.4, 100 mM MgCl2 and 0.5 mg/mL BSA, 250 μM DTT

2.Kinase assay buffer(1X): 40 mM Tris-HCl, pH 7.4, 20 mM MgCl2, 0.1 mg/mL BSA, 50 μM DTT

3.ACVR2A His Tag Protein, Human

4.ADP-Glo Kinase Assay (UA, Catalog # UA070101)

5.Substrate: MBP Protein (Sinobiological, Catalog # M42-51N)

6.Solid white multi-well plate (384-well plate) (Corning, Catalog #3572)

7.Plate Reader (PerkinElmer)

Produce

1.Prepare a substrate/ATP mixture as follows (25 μM example).

Sample Name

Amount (μL)

10 mM ATP Solution

1

Kinase Assay Buffer III (5x)

79

Substrate at 0.5 mg/mL

80


 

2. Dilute the ACVR2A to 40 µg/mL, 20 µg/mL and 10 µg/mL in Kinase Assay Buffer (1x) and dispense 3 μL into each well of a 384-well plate.

3. Initiate the reaction by adding 2 μL of the detection system prepared in Step 1 to each well. Include a detection system with 3 μL Kinase Assay Buffer (1x) as Blank. The reaction volume is 5 μL.

4. Incubate the reaction at room temperature (22–25℃) for 40 minutes.

5.Add 5 μL of ADP-Glo Reagent to the completed reaction, mix briefly and incubate for 40 minutes at room temperature (22–25 ℃).

6.Add 10 μL of Detection Reagent and incubate the plate for 30 minutes at room temperature (22–25 ℃).

7.Read at luminescence, respectively in endpoint mode.

8.Calculate specific activity.

• Standard Curve

1.Dilute the ATP and ADP to 25 μM in Kinase Assay Buffer (1x).

2.Mix 25 μΜ ATP and 25 μM ADP to form an ATP+ADP solution provided below and dispense 5 μL into each well of a 384-well plate.

Well Number

1

2

3

4

5

6

7

8

9

10

11

12

25μM ADP (μL)

100

80

60

40

20

10

5

4

3

2

1

0

25μM ATP (μL)

0

20

40

60

80

90

95

96

97

98

99

100


 

3.Add 5 μL of ADP-Glo Reagent to the completed reaction, mix briefly and incubate for 40 minutes at room temperature (22–25 ℃).

4.Add 10 μL of Detection Reagent and incubate the plate for 30 minutes at room temperature (22–25 ℃).

5.Read at luminescence, respectively in endpoint mode.

6.Detect optical signals and establish conversion curves.

Specific Activity (pmol/min/μg) =

ATP (pmol)-Blank

Incubation time(min) ×amount of enzyme (μg)


 

Picture

Bioactivity

The specific activity of ACVR2A His Tag Tag Protein was determined to be >7 pmol/min/ug as per activity assay protocol.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).